523 related articles for article (PubMed ID: 2567741)
1. Rebound insomnia: a critical review.
Gillin JC; Spinweber CL; Johnson LC
J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
[TBL] [Abstract][Full Text] [Related]
2. Rebound insomnia: duration of use and individual differences.
Merlotti L; Roehrs T; Zorick F; Roth T
J Clin Psychopharmacol; 1991 Dec; 11(6):368-73. PubMed ID: 1770156
[TBL] [Abstract][Full Text] [Related]
3. A review of the safety profiles of benzodiazepine hypnotics.
Roth T; Roehrs TA
J Clin Psychiatry; 1991 Sep; 52 Suppl():38-41. PubMed ID: 1680124
[TBL] [Abstract][Full Text] [Related]
4. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
Mitler MM; Seidel WF; van den Hoed J; Greenblatt DJ; Dement WC
J Clin Psychopharmacol; 1984 Feb; 4(1):2-13. PubMed ID: 6141188
[TBL] [Abstract][Full Text] [Related]
5. Clinical uses and advantages of low doses of benzodiazepine hypnotics.
Vogel G
J Clin Psychiatry; 1992 Jun; 53 Suppl():19-22. PubMed ID: 1613015
[TBL] [Abstract][Full Text] [Related]
6. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
Kales A; Kales JD
J Clin Psychopharmacol; 1983 Apr; 3(2):140-50. PubMed ID: 6132933
[TBL] [Abstract][Full Text] [Related]
7. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
N Engl J Med; 1987 Sep; 317(12):722-8. PubMed ID: 3306380
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
Scharf MB
J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
Soldatos CR; Dikeos DG; Whitehead A
Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials of hypnotics.
Rickels K
J Clin Psychopharmacol; 1983 Apr; 3(2):133-9. PubMed ID: 6132932
[TBL] [Abstract][Full Text] [Related]
11. Sleep laboratory and clinical studies of the effects of triazolam, flunitrazepam and flurazepam in insomniac patients.
Monti JM
Methods Find Exp Clin Pharmacol; 1981; 3(5):303-26. PubMed ID: 6120270
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk.
Grad RM
J Fam Pract; 1995 Nov; 41(5):473-81. PubMed ID: 7595266
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
[TBL] [Abstract][Full Text] [Related]
14. Quazepam: hypnotic efficacy and side effects.
Kales A
Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
[TBL] [Abstract][Full Text] [Related]
15. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
Kales A; Scharf MB; Kales JD; Soldatos CR
JAMA; 1979 Apr; 241(16):1692-5. PubMed ID: 430730
[TBL] [Abstract][Full Text] [Related]
16. [Does a rebound insomnia following benzodiazepine administration exist?].
Ladewig D
Dtsch Med Wochenschr; 1980 Oct; 105(43):1483-4. PubMed ID: 7428651
[No Abstract] [Full Text] [Related]
17. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines.
Kales A; Manfredi RL; Vgontzas AN; Bixler EO; Vela-Bueno A; Fee EC
Clin Pharmacol Ther; 1991 Apr; 49(4):468-76. PubMed ID: 2015735
[TBL] [Abstract][Full Text] [Related]
18. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
Mouret J; Ruel D; Maillard F; Bianchi M
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
[TBL] [Abstract][Full Text] [Related]
19. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
[TBL] [Abstract][Full Text] [Related]
20. Rebound insomnia and elimination half-life: assessment of individual subject response.
Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
